About
Looking for more information?
Contact our responsive and friendly client services team any time.
INVESTOR PRESENTATION - CSL LIMITED
CSL LIMITED
Health Care
CSL Limited (CSL) is a global biotechnology company that develops and delivers innovative medicines that save lives, protect public health and help people with life-threatening medical conditions live full lives. The operational businesses include CSL Behring and Seqirus. The Group operates predominantly in Australia, the USA, Germany, the United Kingdom and Switzerland.
Read moreMarket Cap
133.96b
Price at Close
$294.43
4w avg. Volume
744.40k
4w avg. Turnover
$220.48m
Announcements
| announcement | t+2 movement | date |
|---|---|---|
| -2.30% | 19 Oct 2020 |
| -2.30% | 18 Oct 2020 |
| +0.68% | 16 Oct 2020 |
| +0.68% | 16 Oct 2020 |
| +0.68% | 16 Oct 2020 |
| -1.09% | 14 Oct 2020 |
| -1.09% | 14 Oct 2020 |
| +0.93% | 13 Oct 2020 |
| +1.19% | 07 Oct 2020 |
| +1.19% | 07 Oct 2020 |
Market Data
Current Price
$294.43
52WK HIGH
$342.75
52WK LOW
$242.67
1YR RETURN
+14.62%
1YR RETURN VS. SECTOR
-5.27%
90 DAY RETURN
+7.28%
ASX RANK
1
/2,014
SECTOR RANK
1
/47
SHARES OUTSTANDING
454.97m
CSL LIMITED
Health Care
CSL Limited (CSL) is a global biotechnology company that develops and delivers innovative medicines that save lives, protect public health and help people with life-threatening medical conditions live full lives. The operational businesses include CSL Behring and Seqirus. The Group operates predominantly in Australia, the USA, Germany, the United Kingdom and Switzerland.
Read moreMarket Cap
133.96b
Price at Close
$294.43
4w avg. Volume
744.40k
4w avg. Turnover
$220.48m
ASX:CSL is not raising right now
Want to invest?
Contact Us
(03) 9028 2888
clients@freshequities.com
Address
Level 7, 388 Bourke St
Melbourne VIC 3000
Australia